Drug
Zp9830
Zp9830: highest development phase Phase 1, developed by Zealand Pharma. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Zealand Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZP9830 NCT06682975 | Phase 1 | Healthy Volunteers |
| ZP9830 NCT07733089 | Phase 1 | Plaque Psoriasis |
Latest
No recent events.
Follow Zp9830 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.